Prostate cancer cells treated with an AKT inhibitor have also shown reduced cell growth [82], and colorectal cancer cell growth has been inhibited by combined treatment with cetuximab and the AKT inhibitor AZD5363 [83]. The gene discussed is AKT1; the disease is prostate carcinoma.